http://www.labhoo.com/ en-us Tue, 06 Jan 2009 00:00:00 GMT Copyright: (C) Labhoo.com http://www.labhoo.com/syndication.htm This is an XML content feed of Labhoo Data. It is intended to be viewed in a newsreader or syndicated to another site. 901 Lab Manager Bootcamp http://www.labmanagerbootcamp.com/ http://www.labhoo.com/logodir/4477.jpg 10/22/2008 3/4/2009 Pittcon 2009, Room N427D, McCormick Place, Chicago IL United States Mario Di Ubaldi mariod@labmanager.com 705-528-6888 NEW at Pittcon 2009 - Whether you're a new manager, have some experience or seasoned, Lab Manager Boot Camp will provide lab professionals with the management skills and tools needed to succeed - things they didn't teach you in chemistry class. 808 CHI’S HIGH-CONTENT ANALYSIS 2009 http://www.highcontentanalysis.com/ http://www.labhoo.com/logodir/LG1819.gif 1/6/2009 1/8/2009 San Francisco, CA United States CHI Representative chi@healthtech.com 781 972 5400 www.healthtech.com 844 CHI’S GLP BIOANALYSIS #3 http://www.healthtech.com/glp/overview.aspx?c=652 http://www.labhoo.com/logodir/LG1819.gif 1/7/2009 1/8/2009 San Francisco, CA United States CHI Representative chi@healthtech.com 781 972 5400 The course will provide detailed information and the current state-of-the-art knowledge on “must know” topics such as writing SOP’s, the do’s and don’ts for the GLP audit, and Quality Assurance.Ample time is allocated to each speaker in order to provide an interactive, in-depth tutorial with time for questions, detailed coverage of the subject and discussion of individual problems and situations. The audience will be strongly encouraged to interact, bring problems, discussion points or suggestions in order to brainstorm with the experts and share new information. You will be provided with printed handouts to follow along with the speakers and take notes. 862 ArabLab 2009 www.domnickhunter.com http://www.labhoo.com/logodir/4523_PDH-LOGO online2.jpg 1/10/2009 1/13/2009 The Dubai International Convention and Exhibition Centre United Arab Emirates Steve Carss steve.carss@parker.com 0044 191 4029000 ARABLAB is the No1 Business to Business show for the Analytical Industry and at the forthcoming show, Parker domnick hunter will showcase its range of laboratory gas generators on stand 335. The company will also participate in the events programme with a seminar called ‘how hydrogen generators can improve safety and increase productivity in the laboratory’ and will take place on Saturday 10th January at 11.40am. 18 Arab-Lab 2009 http://www.arablab.com http://www.labhoo.com/logodir/8467_arablab.gif 1/10/2009 1/13/2009 Dubai International Convention and Exhibition Centre United Arab Emirates The ARABLAB Group (Scientific International Exhibi info@arablab.com + 971 4 397 5418 ARABLAB is the No1 Business to Business show for the Analytical Industry. The only trade show for the Analytical Industry that reaches buyers from the growth markets... Middle East & Africa... the Indian Sub-Continent... China & Asia. ARABLAB is the global buying source for tomorrow's technology reaching decision makers and end-users as well as a unique research source focusing on; BIOTECHNOLOGY ANALYTICAL INSTRUMENTATION LABORATORY TECHNOLOGY ROBOTICS & AUTOMATION ENVIRONMENTAL SCIENCES MEASUREMENT & TESTING NANOTECHNOLOGY 845 CHI’S PEPTALK http://www.chi-peptalk.com/ http://www.labhoo.com/logodir/LG1819.gif 1/11/2009 1/16/2009 San Diego, CA United States CHI Representative chi@healthtech.com 781 972 5400 • Second Annual Lyophilization 2009 • Inaugural Current Trends in Dosage Form Development & Biologics Formulation • Inaugural Processes to Optimize Protein Purification & Recovery • Inaugural Cell Culture: Fermentation & Media • Second Annual Protein Production • Fifth Annual Protein Therapeutics • Inaugural Antibodies in Translation • Inaugural Implementing the Next Generation of Antibodies • Twelfth Annual Protein Expression • Eighth Annual Protein Diagnostic Development 853 ADME PK/TK and Drug Metabolism in Drug Discovery and Development http://www.mondialresearchgroup.com/images/Training.pdf 1/20/2009 1/21/2009 Bruss Belgium Mondial Research Group cristinah@mondialresearchgroup.com 0044 208 144 7170 This course is specifically designed for personnel in the pharmaceutical and biotechnology industries and contract research organizations (CROs) who need to understand the requirements for ADME (absorption, distribution, metabolism, elimination), pharmacokinetics/toxicokinetics (PK/TK) and drug metabolism (DM) experiments during the drug discovery and development processes. Participants should have some knowledge of these processes and desire to learn more about how ADME, PK/TK, and DM studies are designed, conducted, and interpreted in order the characterize the fate of a drug candidate. Nonclinical and clinical scientists, managers, and project team leaders at pharmaceutical companies and related industries will gain a detailed understanding of the types of ADME, PK/TK, and DM research studies conducted to support submissions to regulatory authorities. The content of this course will assist pharmaceutical, biotechnology, and CRO researchers and managers in understanding the requirements for a well-designed and successful ADME, PK/TK, and DM program that is conducted within a drug development logic plan and in compliance ICH guidelines. The various types of ADME, PK/TK, and DM studies, which include in vitro metabolism and delivery, animal and human pharmacokinetics, protein binding, mass balance, tissue distribution, metabolite isolation and identification, and toxicokinetic support, will be discussed. Study designs and potential results, with possible interpretations, from each of the study types will be presented. The generation study reports and summaries, both of which are to be included in submissions to regulatory authorities, for completed research experiments will be delineated. 831 Stem Cells World Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 1/20/2009 1/22/2009 Palm Springs, California United States Sara Sharpe s.sharpe@selectbiosciences.com 01787 315110 Welcome to the 3rd annual Stem Cells World Congress. This year's event will be held in beautiful Palm Springs, California - definitely the place to be in January! The conference will be co-located with the World Biobanking Summit. Registered delegates will have access to both meetings ensuring a very cost-effective trip. 852 Predictive Human Toxicity and ADME/Tox Studies http://www.mondialresearchgroup.com/index.php?whereTo=humt09 1/22/2009 1/23/2009 Brussels , Belgium Belgium Mondial Research Group cristinah@mondialresearchgroup.com 0044 208 144 7170 Following the success of previous years, Mondial Research Group is proud to present it's 4th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies and looks to build on a growing reputation as it becomes the defacto meeting of its kind. Mondial Research Group along with its strategic partners will bring together scientific experts to present and discuss the most recent advances towards accurately predicting human toxicities, and how to implement successful screening earlier in the drug discovery process. This event will cover topics on toxicogenomics, in-silico tools, ADME, Toxicology and Pharmacokinetics and much more. 846 CHI’S BIOMARKER ASSAY DEVELOPMENT http://www.healthtech.com/bma/overview.aspx?c=6592 http://www.labhoo.com/logodir/LG1819.gif 1/26/2009 1/28/2009 San Diego, CA United States CHI Representative chi@healthtech.com 781 972 5400 The increasing importance of biomarkers in the drug discovery process calls for a comprehensive biomarker strategy that must include assay development and validation. CHI’s Inaugural Biomarker Assay Development meeting addresses “fit-for-purpose” method development, spanning pre-clinical and clinical drug development, as well as diagnostics. The meeting will provide an overview of novel assay platforms for genomic and proteomic analysis, as well as multiplexed assays, flow cytometry, and more. It will also discuss the pros and cons of developing the assay in-house vs. adopting off-the-shelf solutions/kits vs. outsourcing. And finally, since the meeting is co-located with the Translational Cancer Medicine meeting, it will also focus on biomarker assays in oncology. 847 CHI’S TRANSLATIONAL CANCER MEDICINE http://www.healthtech.com/trm/overview.aspx?c=6593 http://www.labhoo.com/logodir/LG1819.gif 1/26/2009 1/28/2009 San Diego, CA United States CHI Representative chi@healthtech.com 781 972 5400 The increasing technological advances in biomarker and target discovery, pre-clinical models, personalized medicine, and clinical trial design have the potential to expedite the translation of new discoveries to clinical practice. Oncology is the area that has perhaps benefited the most from these new technologies. The Translational Cancer Medicine meeting will identify the key opportunities to improve cancer diagnosis and treatment, as well as provide case studies of successful (and not so successful) drug development. The pre-conference workshop will provide a comprehensive survey of novel cancer biomarkers. Translational Cancer Medicine is co-located with the Biomarker Assay Development meeting. 910 13th Annual BioIndustry Association Gala Dinner http://www.bioindustry.org http://www.labhoo.com/logodir/1231_bia.jpg 1/29/2009 1/29/2009 Natural History Museum, London United Kingdom BIA ksmith@bioindustry.org Get 2009 off to a flying start- come and join us at this prestigious black tie event and meet old friends, make new contacts and enjoy the surroundings of this unique venue. The evening starts at 7pm with a Champagne Reception sponsored by SV Life Science Advisers LLP and will be followed by a delicious three course meal with wine and coffee. The Gala Dinner, kindly sponsored by bioProcess UK, Giles Insurance, Nomura Code Securities and Shire plc, is the BIA’s premier networking event and attracts over 600 industry professionals from the UK’s leading bioscience companies To round-up the evening guests will have the opportunity for extensive networking, to enjoy a fun casino and the bar facilities. 888 Orphan Diseases http://http://www.ibclifesciences.com/Orphan/overview.xml 2/5/2009 2/6/2009 Hyatt Regency Bethesda * Bethesda, MD United States IBC Life Sciences reg@ibcusa.com (800) 390-4078 IBC's Inaugural Orphan Diseases conference is the premier conference to attend if you are involved or interested in research and discovery, drug development, clinical trials, regulatory affairs, funding or the commercialization of orphan disease therapies and cures. 848 ASAP 2009 GLOBAL ALLIANCE SUMMIT http://www.healthtech.com/sap/overview.aspx http://www.labhoo.com/logodir/LG1819.gif 2/9/2009 2/12/2009 Ft. Lauderdale, FL United States CHI Representative chi@healthtech.com 781 972 5400 907 Success can be built in times of crisis - A unique MedTech event http://pr4.netatlantic.com/t/1199603/8393850/66956/0/ http://www.labhoo.com/logodir/1231_bia.jpg 2/10/2009 2/10/2009 London United Kingdom BioIndustry Association ksmith@bioindustry.org Success can be built in times of crisis - A unique MedTech event on 10 Feb 09, Central London MedTech offers the potential for high returns growth, but often in a shorter timeframe than life sciences. An investment in bio-tech may take between four to seven years to mature compared with as little as two or three years in MedTech. That is an increasingly attractive prospect for investors in the current market. The BIA and NESTA are pleased to announce a joint MedTech Investing Forum taking place on the 10 February 2009, 4-8pm in Central London. This exciting early evening event will bring together the UK's leading MedTech investors, over 30 MedTech companies and a host of companies looking to in-license or acquire MedTech technologies and know-how. The afternoon will start with a panel session of investors who will explore their investment interests and will discuss case studies to illustrate their points. Following the panel session, a board level industry leader of a major MedTech company will give a perspective on the current landscape and the event will close with a MedTech success story...someone who's been there. Speaker names to be announced shortly. Networking and drinks will follow. This event is free to attend. 782 ADMET Europe http://www.selectbiosciences.com/conferences/SE_MED_AD09/index.aspx http://www.labhoo.com/logodir/8688_SB88.gif 2/23/2009 2/25/2009 Berlin Germany Helen Read h.read@Selectbiosciences.com +44 (0) 1787 315110 The 2nd annual ADMET Europe conference will be held in Berlin, Germany. Co-located with Screening Europe and MedChem Europe, and sharing an exhibition, registration will allow access to all 3 meetings, ensuring a very cost-effective trip. 913 Complete GC http://www.anthias.co.uk/training-courses http://www.labhoo.com/logodir/LG43251.jpg 2/23/2009 2/27/2009 Amsterdam Netherlands Maureen Nicholas mmn@anthias.co.uk 01480 831262 3-day Practical Essentials of Gas Chromatography and 2-day The GC Clinic 781 MedChem Europe http://www.selectbiosciences.com/conferences/SE_MED_AD09/index.aspx http://www.labhoo.com/logodir/8688_SB88.gif 2/23/2009 2/25/2009 Berlin Germany Helen Read h.read@Selectbiosciences.com +44 (0) 1787 315110 The 5th annual MedChem Europe conference will be held in Berlin, Germany. Co-located with Screening Europe and ADMET Europe, and sharing an exhibition, registration will allow access to all 3 meetings. To accommodate even more talks this year the SE and MC conferences will be extended to 3 days. 779 Screening Europe http://www.selectbiosciences.com/conferences/SE_MED_AD09/ http://www.labhoo.com/logodir/8688_SB88.gif 2/23/2009 2/25/2009 Berlin Germany Helen Read h.read@Selectbiosciences.com +44 (0) 1787 315110 The 6th annual Screening Europe conference will be held in Berlin, Germany. Co-located with MedChem Europe and ADMET Europe, and sharing an exhibition, registration to SE will allow access to all 3 meetings. To accommodate even more talks this year the SE and MC conferences will be extended to 3 days. 889 TIDESAsia http://www.ibclifesciences.com/AsiaTIDES/overview.xml 2/23/2009 2/25/2009 Sheraton Miyako Hotel * Tokyo, Japan None Selected IBC Life Sciences reg@ibcusa.com (800)390-4078 IBC's Inaugural AsiaTIDES is the only event that brings worldwide best practices in development strategies for oligonucleotide and peptide-based therapeutics including formulation and delivery, and regulatory updates—to Japan. 849 CHI’S MOLECULAR MEDICINE TRI-CONFERENCE http://www.tri-conference.com http://www.labhoo.com/logodir/LG1819.gif 2/24/2009 2/27/2009 San Francisco, CA United States CHI Representative chi@healthtech.com 781 972 5400 The Fifteenth International Molecular Medicine Tri-Conference delivered the hottest areas of biotechnology brought together in one location. Molecular Diagnostics, Medicinal Chemistry, Stem Cells and Translational Medicine were the buzz at this year’s event. The presenters delivered pragmatic and solution-driven insights that captivated the audience and the exhibit hall delivered more technologies than ever before. Attendance hit historic levels reaching 2800 delegates for first time. The continued growth of the event is a strong indicator that the confluence of biology, chemistry and business is being realized. 783 Drug Discovery Latin America http://www.selectbiosciences.com/conferences/DDLA2009/ http://www.labhoo.com/logodir/8688_SB88.gif 2/26/2009 2/27/2009 Rio de Janeiro Brazil Stephen Mudd s.mudd@Selectbiosciences.com +44 (0) 1787 315110 The inaugural Drug Discovery Latin America conference and exhibition; to review the status of drug discovery activities in Latin America and to assist its future development. Business and research leaders from developed markets and BRIC countries will bring their knowledge and experience to share. 870 CHI’S THE GREENING OF PHARMA http://www.healthtech.com/gph/overview.aspx?c=6627 http://www.labhoo.com/logodir/LG1819.gif 3/2/2009 3/3/2009 Boston, MA United States CHI Representative chi@healthtech.com 781 972 5400 This premier CHI “Greening of BioPharma” Conference creates a unique forum bringing together, in one place, BioPharmaceutical company Real Estate Executives, Engineers, and Laboratory and Manufacturing Facilities Management Executives and Senior Managers with leading BioPharmaceutical laboratory and manufacturing facilities architects, construction firms, biopharmaceutical process design and systems companies and equipment vendors to define the future of “The Greening of BioPharma”. This conference will address the specialized issues and challenges unique to the Biotech and Pharmaceutical industries and how leading companies have met these challenges. 885 Outsourcing Manufacturing of Biopharmaceuticals http://www.IBCLifeSciences.com/outsourcing 3/2/2009 3/3/2009 La Costa Resort and Spa, Carlsbad, CA United States IBC Life Sciences Reg@ibcusa.com (800) 390-4078 883 Process Validation for Biopharmaceuticals http://www.IBCLifeSciences.com/process 3/2/2009 3/3/2009 La Costa Resort and Spa, Carlsbad, CA United States IBC Life Sciences reg@ibcusa.com (800) 390-4078 884 Technology Transfer for Biopharmaceuticals http://www.IBCLifeSciences.com/transfer 3/2/2009 3/3/2009 La Costa Resort and Spa, Carlsbad, CA United States IBC Life Sciences reg@ibcusa.com (800) 390-4078 887 Antibody Development and Production http://www.IBCLifeSciences.com/antibodyprod 3/4/2009 3/6/2009 La Costa Resort and Spa, Carlsbad, CA United States IBC Life Sciences reg@ibcusa.com (800) 390-4078 886 Non-Antibody Protein Therapeutic Development and Production http://www.IBCLifeSciences.com/nonanitbody 3/4/2009 3/6/2009 La Costa Resort and Spa, Carlsbad, CA United States IBC Life Sciences reg@ibcusa.com (800) 390-4078 865 Pittcon http:// http://www.labhoo.com/logodir/4523_PDH-LOGO online2.jpg 3/8/2009 3/13/2009 McCormick Place, Chicago, IL, USA United States Jane Sexton jane.sexton@parker.com Pittcon is the premier conference and exposition on laboratory sciences and the most comprehensive annual meeting on laboratory science in the world. Parker domnick hunter will be exhibiting at the forthcoming event. 850 CHI’S DRUG DEVELOPMENT LATIN AMERICA http://www.healthtech.com/lam/overview.aspx?c=6606 http://www.labhoo.com/logodir/LG1819.gif 3/9/2009 3/10/2009 Miami, FL United States CHI Representative chi@healthtech.com 781 972 5400 The globalization of R&D into emerging regions continues. Growing R&D spending in these regions has been driven by many factors including the attractiveness of commercial markets there, more favorable economics including lower relative costs for greater speed, access to highly skilled professional labor and a large pool of patients, particularly treatment-naïve ones. 871 CHI’S ELECTRONIC DATA IN CLINICAL TRIALS http://www.healthtech.com/edc/overview.aspx?c=6605 http://www.labhoo.com/logodir/LG1819.gif 3/11/2009 3/12/2009 Miami, FL United States CHI Representative chi@healthtech.com 781 972 5400 New technology is available and being created everyday to make the collection, correction and assessment of data from clinical trials more efficient. How do you decide which technology to use and when to use it? What are the common problems with implementation and how do you resolve them. This inaugural conference is being organized to address these issues. 858 Protein Purification: Principles & Practice http://www.healthtech.com/Conferences_Overview.aspx?id=77982 http://www.labhoo.com/logodir/LG1819.gif 3/15/2009 3/20/2009 New Brunswick, NJ United States CHI Representative chi@healthtech.com 781 972 5400 A 5 ½ day hands-on laboratory course in which participants will learn skills to effectively design separation and purification strategies for downstream processing. This course uses the remarkable Green-Fluorescent Protein (GFP), a novel marker for gene expression, as the source material. While this is a general course applicable to all proteins, we use GFP as a highly effective visual teaching tool. More than 1200 scientists from around the world have strongly recommended this intensive course as an opportunity to develop protein research and analytical skills in a retreat setting. Participants work hard, identify and solve problems in the lab and enjoy camaraderie and good food and drink with colleagues. This five and one half day laboratory course covers a wide variety of conventional methods for protein isolation, purification, and characterization. The course format integrates hands-on laboratory exercises with classroom lectures, demonstrations, study breaks, and short take-home assignments. 873 CHI’S COMPREHENDING COPY NUMBER VARIATION http://www.healthtech.com/cgh/overview.aspx http://www.labhoo.com/logodir/LG1819.gif 3/16/2009 3/17/2009 San Diego, CA United States CHI Representative chi@healthtech.com 781 972 5400 All agree that copy number variation (CNV) contributes substantially to human genetic diversity. But to what extent? The resulting applications of newly developed whole-genome scanning technologies have catalyzed the appreciation of CNV in the genetic community. The range of these promising new technologies will, for the first time, allow scanning of the entire human genome for CNV in a single experiment. As these genome-wide scanning techniques become more widely used in diagnostic laboratories, the major challenge is how to accurately interpret which submicroscopic genomic imbalances are pathogenic in nature and which are benign. 872 CHI’S QUANTITATIVE PCR http://www.healthtech.com/qpc/overview.aspx http://www.labhoo.com/logodir/LG1819.gif 3/16/2009 3/17/2009 San Diego, CA United States CHI Representative chi@healthtech.com 781 972 5400 PCR’s sensitivity, specificity, and simplicity has revolutionized molecular biology in basic, industrial, and clinical settings. Technologies abound including quantitative PCR (qPCR), multiplex qPCR, real-time PCR, and reverse transcription quantitative PCR (RT-qPCR). Your technology selection is determined by the source of nucleic acid. However, complexities arise because of multiple assays, numerous protocols, abundant sources, lack of assay standardization, differences in sample processing, ineffective use of controls, normalization methods, and quality control management. Researchers face challenges in reliability, relevance, and reproducibility. Learn from savvy, seasoned researchers as they share their real-world experiences, applications, and results at Cambridge Healthtech Institute’s 5th Annual Quantitative PCR. 874 CHI’S NEXT-GENERATION SEQUENCING http://www.healthtech.com/seq/overview.aspx http://www.labhoo.com/logodir/LG1819.gif 3/18/2009 3/19/2009 San Diego, CA United States CHI Representative chi@healthtech.com 781 972 5400 Next-generation sequencing is driving growth within the basic and biomedical research community as rapidly as the bases are being sequenced. All agree however, with the implementation of any new technology there is a balancing act of cost-quality-quantity. What is your sequencing goal? The potential applications are as numerous as the samples to be analyzed. Each next-gen platform is optimized for specific sequencing applications. Cambridge Healthtech Institute’s 3rd Annual Next-Generation Sequencing offers an unparalleled opportunity to compare and contrast the next-generation sequencing platforms to best suit your research needs. 875 CHI’S THE CHALLENGE OF ANTIBACTERIAL DRUG DEVELOPMENT http://www.healthtech.com/bac/overview.aspx?c=694 http://www.labhoo.com/logodir/LG1819.gif 3/18/2009 3/19/2009 San Diego, CA United States CHI Representative chi@healthtech.com 781 972 5400 Resistant bacterial strains are becoming an increasing challenge for the pharmaceutical industry. There is a growing need to develop novel defense mechanisms and novel strategies to treat bacterial infections. In recent years, scientists have focused increasingly on developing novel concepts and improving leads to overcome the challenge of resistance. The interaction of biology and chemistry is key to the solution of this problem. 876 CHI’S MICRORNA IN HUMAN DISEASE AND DEVELOPMENT http://www.healthtech.com/mrn/overview.aspx?c=662 http://www.labhoo.com/logodir/LG1819.gif 3/23/2009 3/25/2009 Boston, MA United States CHI Representative chi@healthtech.com 781 972 5400 Although microRNAs were brought into the spotlight only recently, their role in regulating mammalian development and disease has become clear. miRNAs represent a novel class of targets for therapeutic and diagnostic development, currently not fully exploited by the pharmaceutical and biotechnology industries. Cambridge Healthtech Institute’s Fifth Annual microRNA in Human Disease and Development meeting is specifically designed to address the role of miRNA in human development and disease, and to explore the impact of this new research for drug and diagnostic development. The meeting will cover progress in identifying human miRNA, technologies used for miRNA profiling, and the latest research in linking miRNA to human disease. Opportunities for using miRNA as diagnostic biomarkers and a novel class of targets for therapeutic development will be explored. 890 Targeting Metabolic Disease http://www.ibclifesciences.com/metabolic/8838.xml 3/23/2009 3/25/2009 Courtyard Boston Downtown Tremont Hotel * Boston, MA United States IBC Life Sciences reg@ibcusa.com (800) 390-4078 689 China R&D Summit http://www.IBCLifeSciences.com/China 4/6/2009 4/8/2009 Grand Hyatt Hotel • Shanghai China China IBC Asia Customer Service enquiry@ibcasia.com.sg +65 6835 5136 Integrate China into your global strategy – from R&D to clinical trials. Hear first-time case studies, industry insights and exciting panel discussions on controversial topics to help you leverage China as your global partner in licensing, outsourcing or joint research and development. 834 Advances in Synthetic Chemistry http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 4/16/2009 4/17/2009 Edinburgh, Scotland United Kingdom Sara Sharpe s.sharpe@selectbioscience.com +44 (0)1787 315110 Welcome to the 2nd annual Advances in Synthetic Chemistry conference and exhibition. This year's event will be held in the beautiful and historic city of Edinburgh. 892 Advances in Synthetic Biology http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 4/28/2009 4/29/2009 London United Kingdom Sam Marsden s.marsden@selectbiosciences.com +44(0)1787 315120 Welcome to the Advanced Synthetic Biology conference and exhibition. Synthetic biology is the design and construction of new biological parts, devices and systems (and the re-design of existing, natural biological systems) for useful purposes. 684 BioProcess International Analytical and Quality Summit http://www.IBCLifeSciences.com/Analytical 5/4/2009 5/6/2009 Estancia La Jolla Resort * La Jolla, CA United States IBC Customer Service reg@ibcusa.com (800) 390-4078 906 5th High Throughput Medicinal Chemistry Conference: New Technologies in Synthesis and Medicinal Chemistry https://www.ya-ya.co.uk/rsc/delegate_registration_form.php 5/12/2009 5/12/2009 AstraZeneca, Alderley Park, Cheshire United Kingdom AstraZeneca The application of technology in synthetic chemistry has now become routine. Since its inception, the RSC’s High Throughput Chemistry & New Technologies subject group has sought to highlight significant advances in the field. As you can see, this year’s conference has an exciting speaker line up focusing on both technology-enabled drug discovery, as well as new synthetic technologies with particular relevance to medicinal chemistry. AGENDA: 09.00 Registration and Coffee Introduction Session 1 10.00 Rob Maleczka, Michigan State University (CH activation) Greg Fu, MIT (Pd Coupling) Paul Watts, University of Hull (Flow Chemistry) Lunch, lab tours, equipment exhibition, posters Session 2 14.00 Masad Damha, McGill University (siRNA Synthesis & Medchem) Steven Woodward, Astex Therapeutics (Fragment based Drug Discovery) Coffee Session 2 15.30 Paul Wyatt, University of Dundee (Drug Discovery in Academia) John G. Cumming, AstraZeneca (Small is Beautiful: Drug-like properties and Candidate Attrition) Wine reception 835 DxRx Summit http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 5/12/2009 5/13/2009 Boston, MA United States Helen Reid h.reid@selectbiosciences.com +44 (0) 1787 315110 Welcome to the Nucleic Acid Diagnostics & Therapeutics Summit. This inaugural summit will be be held in Boston, MA immediately prior to the annual RNAi World Congress, which will address the latest research in RNAi and microRNA research. 836 RNAi World Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 5/14/2009 5/15/2009 Boston, MA United States Helen Read h.read@selectbiosciences.com +44 (0)1787 315110 Welcome to the 3rd annual RNAi World Congress. This year's event will be held in Boston, home to many of the world's top institutions engaged in gene silencing research. 682 TIDES: Oligonucleotide and Peptide® Technology and Product Development http://www.IBCLifeSciences.com/TIDES 5/17/2009 5/20/2009 Red Rock Casino, Resort and Spa • Las Vegas, NV United States IBC Customer Service reg@ibcusa.com (800) 390-4078 Join 600+ attendees at the conference that addresses manufacturing technologies for oligonucleotide and peptide-based technologies, as well as drug development strategies to help you accelerate your product development 839 Advances in Microarray Technology http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 5/19/2009 5/20/2009 Stockholm Sweden Sara Sharpe s.sharpe@selectbiosciences.com +44 (0)1787 315110 Welcome to the 5th annual Advances in Microarray Technology (AMT) conference where you will hear about the latest developments and applications in the rapidly expanding field of microarrays. 838 Lab-on-a-Chip European Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 5/19/2009 5/20/2009 Stockholm Sweden Sara Sharpe s.sharp@selectbiosciences.com +44 (0) 1787 315110 Welcome to the 3rd annual Lab-on-a-Chip European Congress, designed to review existing and new life science applications of microfluidic technologies. 840 Molecular Diagnostics Europe http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 5/19/2009 5/20/2009 Stockholm Sweden Sara Sharpe s.sharpe@selectbiosciences.com +44 (0)1787 315110 Welcome to the inaugural Molecular Diagnostics Europe conference. Agenda Topics may include: Trends and Emerging Technologies in Molecular Diagnostics, PGx and Personalized Medicine. 690 Drug Discovery and Development Partnering, Licensing and R&D Innovation Summit JAPAN http://www.IBCLifeSciences.com/Japan 6/1/2009 6/3/2009 Keio Plaza Hotel * Tokyo, Japan United States IBC Asia Customer Service info@ibcasia.com.sg +65 6835 5136 903 Cancer Proteomics http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 6/8/2009 6/11/2009 Dublin Ireland Ken Browne admin@selectbiosciences.com +44(0)1787 315110 Organized in association with UCD and supported by EMBO, the aim is to create a translational framework by which proteomics investigations can advance our knowledge of cancer-related processes and ultimately be utilized in a clinical context. 686 Cell Line Development and Engineering http://www.IBCLifeSciences.com/CellLine 6/22/2009 6/24/2009 Hilton La Jolla Torrey Pines • La Jolla, CA United States IBC Customer Service reg@ibcusa.com (800) 390-4078 Increased demand to maximize protein expression levels is driving the need for scientists to quickly identify the best cell lines and work together with engineers to develop, integrate and optimize the most robust processes. IBC's 3rd Cell Line Development and Engineering event is the only industry forum that brings together forward-thinking academics with industry leaders to report on the latest advances that are occurring during every stage of the process from molecular biology through manufacturing. 904 AgriGenomics World Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 7/2/2009 7/3/2009 London United Kingdom Sam Marsden s.marsden@selectbiosciences.com +44(0)1787 315120 Welcome to the second annual AgriGenomics World Congress. AgriGenomics is the detailed study of the genetic makeup of the plant and how all the genes work together to produce the crop. 767 Drug Discovery & Development of Innovative Therapeutics http://www.drugdisc.com 8/3/2009 8/6/2009 World Trade Center Boston & Seaport Hotel -- Boston, MA United States IBC Life Sciences reg@ibcusa.com (800) 390-4078 893 Target Discovery World Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 8/4/2009 8/5/2009 South San Francisco, CA United States Helen Read h.read@selectbiosciences.com +44(0)1787 315112 Welcome to the Target Discovery World Congress, combining our successful Screening and Ion Channel Targets conferences 894 Lab-on-a-Chip World Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 8/6/2009 8/7/2009 South San Francisco, CA United States Sara Sharpe s.sharpe@selectbiosciences.com +44(0)1787 314956 Welcome to the Lab-on-a-Chip World Congress, designed to review existing and new life science applications of microfluidic technologies. 895 Microarray World Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 8/6/2009 8/7/2009 South San Francisco, CA United States Sara Sharpe s.sharpe@selectbiosciences.com +44(0)1787 314956 Welcome to the Microarray World Congress where you will hear about the latest developments and applications in the rapidly expanding field of microarrays. 896 Molecular Diagnostics World Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 8/6/2009 8/7/2009 South San Francisco, CA United Kingdom Sara Sharpe s.sharpe@selectbiosciences.com +44(0)1787 314956 Welcome to the 2nd Molecular Diagnostics World Congress which will be co-located with the Microarray World Congress and Lab-on-a-Chip World Congress 898 Advances in qPCR http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 9/17/2009 9/18/2009 Berlin Germany Helen Read h.read@selectbiosciences.com +44(0)1787 315112 Welcome to the 2nd annual Advances in qPCR conference and exhibition. The conference will be co-located with RNAi Europe, Peptides Europe and the Epigenetics World Congress. 899 Epigenetics World Congress http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 9/17/2009 9/18/2009 Berlin Germany Helen Read h.read@selectbiosciences.com +44(0)1787 314956 Welcome to the inaugural Epigenetics World Congress. The conference will be co-located with the Advances in qPCR, Peptides Europe and RNAi Europe conferences. 900 Peptides Europe http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 9/17/2009 9/18/2009 Berlin Germany Helen Read h.read@selectbiosciences.com +44(0)1787 315120 Welcome to the inaugural Peptides Europe conference and exhibition. The conference will be co-located with RNAi Europe, Advances in qPCR, and the Epigenetics World Congress. 902 RNAi Europe http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 9/17/2009 9/18/2009 Berlin Germany Helen Read h.read@selectbiosciences.com +44(0)1787 315120 Welcome to the 6th annual RNAi Europe - Europe's largest conference & exhibition dedicated to RNA interference. The conference will be co-located with Advances in qPCR, Peptides Europe, and the Epigenetics World Congress. 911 Stem Cells Europe http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 9/23/2009 9/25/2009 Edinburgh, Scotland United Kingdom Sara Sharpe s.sharpe@selectbiosciences.com +44(0)1787 314956 Welcome to the 2nd Annual Stem Cells & Regenerative Medicine Europe conference. The agenda will reflect the dynamic nature of the field as we move from fundamental stem cell research towards clinical therapies. With a multidisciplinary range of speakers the meeting, co-located with the World Biobanking Summit, truly encompasses “bench to bedside” stem cell research. 912 World Biobanking Summit http://www.selectbiosciences.com http://www.labhoo.com/logodir/8688_SB88.gif 9/24/2009 9/25/2009 Edinburgh, Scotland United Kingdom Sara Sharpe s.sharpe@selectbiosciences.com +44(0)1787 314956 Welcome to the inaugural World Biobanking Summit and exhibition. The conference will be co-located with Stem Cells Europe. Registered delegates will have access to both meetings ensuring a very cost-effective trip. 685 BioProcess International™ Conference & Exhibition www.IBCLifeSciences.com/BPI/US 10/12/2009 10/16/2009 Raleigh Convention Center * Raleigh, NC United States IBC Customer Service reg@ibcusa.com (800) 390-4078 BioProcess International™ is THE meeting place for the bioprocessing industry. 909 13th IAIN World Congress http://www.congrex.com/nnf/iain2009/welcome.asp 10/27/2009 10/30/2009 Stockholm Sweden Anna Jensen, Nordic Institute of Navigation iain2009@congrex.com +46 8 459 66 00 The tri-annual congress of the International Association of Institutes of Navigation - IAIN takes place in Stockholm, Sweden, October 27-30, 2009. The programme will cover the latest developments within civilian and military navigation and positioning on land and sea, in the air and in space